Jing Chen is an accomplished biomedical professional with extensive experience in cancer biology and immunology. At HitGen Inc., Jing served as Executive Director and previously as Senior Director in the Biology department from May 2024 to June 2025. Prior experience includes a role as Senior Scientist II in Discovery Biotherapeutics at Exelixis from January 2022 to January 2024, and as Associate Director of Cancer Biology & Immunology at Crown Bioscience, Inc. from January 2019 to January 2022. Jing's research experience at Duke University from January 2011 to January 2019 encompasses roles as Senior Research Associate and Research Scientist in Pharmacology & Cancer Biology. Earlier positions include Staff Scientist and Postdoctoral Research Associate at St. Jude Children's Research Hospital from January 2005 to January 2011. Scholarly training includes participation in the Duke Regulatory Affairs On Site Training Program and the NCRAF RAC workshop in 2016.
This person is not in any teams
This person is not in any offices